You are here
Basics of therapeutic goods regulation
What are some key terms I need to understand?
If you have not previously been involved in regulation of therapeutic goods, here are some key terms that might be useful to know.
Australian Register of Therapeutic Goods (ARTG)
The ARTG is an electronic register of therapeutic goods that can be lawfully supplied in Australia, and provides information such as the product name, active ingredients (in the case of products such as medicines), classification (in the case of medical devices), sponsor and manufacturer.
More about the ARTG
Every ARTG entry belongs to a sponsor, and they are responsible for applying for and maintaining the ARTG entry. If someone else has an ARTG entry for a particular therapeutic good, that does not make it legal for you to import or supply that therapeutic good, even if the manufacturer is the same.
To supply a therapeutic good, you need to have:
- your own ARTG entry for that therapeutic good, or
- a retail arrangement with a sponsor who has an ARTG entry for that therapeutic good
To import or export a therapeutic good, you need to have your own ARTG entry.
There are special circumstances where therapeutic goods not on the ARTG can be lawfully supplied. For more information: Accessing unapproved products
Additionally, there are certain products not on the ARTG that are not considered unapproved, such as custom-made medical devices and homeopathic remedies.
For more information about the ARTG: Searching the ARTG
Conformity assessment (for medical devices)
Conformity assessment is the way by which a manufacturer demonstrates a device (and the process to manufacture it) meets safety, quality and performance requirements. For more information:
Good manufacturing practice (GMP) (for medicines and biologicals)
GMP describes a set of principles and procedures that seek to ensure the manufacture of medicines and biologicals are consistent and of high quality.
More about GMP
GMP is based on the principle that:
- quality cannot be tested into a batch of product
- quality must be built into each batch of product during all stages of the manufacturing process
There are different codes of GMP, depending on the type of therapeutic good and whether or not it originates from human blood or tissue.
Indication / intended use / intended purpose
Indication (registered medicines, listed medicines, Class 3 & 4 biologicals), intended use (Class 2 biologicals), and intended purpose (medical devices) are words used to describe the specific therapeutic use of a product.
If you are producing the therapeutic goods, or are involved in any part of producing the therapeutic goods, you are involved in manufacture.
There are subtle differences between these definitions as they apply to manufacturing of medicines and biologicals, and manufacturing of medical devices.
More about manufacture
Manufacture does not just consist of making tablets or putting a medical device together. Many of the steps leading up to these steps are part of manufacturing, as are the packaging and labelling steps.
Manufacture of goods that are not medical devices is described in Section 3 of the Therapeutic Goods Act 1989 as:
- producing the goods, or
- engaging in any part of the process of producing the goods or bringing the goods to their final state, including engaging in the processing, assembling, packaging, labelling, storage, sterilising, testing or releasing for supply of the goods or of any component or ingredient of the goods as part of that process.
A manufacturer of medical devices is described in Section 41BG of the Therapeutic Goods Act 1989:
- the person who is responsible for the design, production, packaging and labelling of the device before it is supplied under the person's name, whether or not it is the person, or another person acting on the person's behalf, who carries out those operations
Note that this is not the entire definition of a manufacturer of a medical device. For more information, go to Section 41BG of the Therapeutic Goods Act 1989.
Australian manufacturers of medicines and biologicals need to obtain a TGA licence. For more information: Guidance on licensing/certification inspections.
All medical devices seeking inclusion in the ARTG (except for Class I non-sterile or non-measuring devices) require conformity assessment certification to support their ARTG application. That certification may be obtained from TGA or from a European notified body with the appropriate authority.
Post market monitoring
Once your product is being supplied, you have ongoing responsibilities and legal obligations. You need to advise us of any issues relating to your product to ensure that it continues to meet regulatory requirements.
The TGA also has a key role to play. We receive and manage adverse event reports from health professionals and the community, and work with overseas regulators.
A sponsor is the person or organisation who exports, imports or manufactures a therapeutic good (for supply in Australia or elsewhere), or arranges for another party to do any of these things. They have to be a resident of Australia, part of a company in Australia, or conducting business in Australia.
More about sponsors
The person or organisation who applies for registration, listing or inclusion of a product on the ARTG becomes the sponsor once the product is approved, and their product must be entered on the ARTG before it can be sold in Australia.
A full definition of a sponsor can be found in Chapter 1, Section 3 of the Therapeutic Goods Act 1989.
Under special circumstances where the therapeutic good is not included on the ARTG, you may still be considered the sponsor and the good can still be lawfully supplied (such as for clinical trials). For more information: Accessing unapproved products
Responsibilities of sponsors
All sponsors of therapeutic goods, whether the good is on the ARTG or not, have a number of responsibilities. As a sponsor, you need to be able to:
- obtain information from the manufacturer when requested by the TGA
- comply with requirements for records of distribution and supply
- notify the TGA of adverse events or problems with the goods you sponsor
- notify the TGA of an issue that needs to be corrected, such as a recall
- undertake regulatory actions relevant to the products supplied, where necessary
- comply with the requirements for advertising therapeutic goods
- ensure all fees and charges issued to your organisation by the TGA are paid
Note: The list above does not describe every sponsor obligation. See our training session on sponsor obligations.
Sponsors often need to apply on behalf of overseas manufacturers
Australian manufacturers often also sponsor their own products; they can apply directly to the TGA to enter their products on the ARTG. If a product is manufactured overseas, however, the application for entry on the ARTG needs to be made by an eligible sponsor.
Sponsors have a relationship with overseas medicine manufacturers
It is essential the sponsor has a formal relationship with the overseas manufacturer because they will undertake a range of responsibilities on the manufacturer's behalf, such as:
- applying for GMP clearance for medicines and some biologicals that are regulated overseas in the same way they are in Australia, and have therefore already been inspected by an acceptable regulator via desktop assessment. For more information: GMP clearance for overseas manufacturers
- organising for the TGA to inspect the overseas manufacturer if GMP certification is necessary - for example, for some complementary medicines, sunscreens and biologicals or where there is no evidence for a GMP Clearance via the desktop assessment pathways. For more information: Guidance on licensing/certification inspections
- undertaking post-market responsibilities such as adverse event reporting.
If a person is receiving a therapeutic good from you through sale, gift, lease, loan, hire or hire-purchase, you are a supplier of that therapeutic good. This includes if it is free of charge (such as a sample or through product testing), or even if you're supplying the product through administration or applying treatment.
More about supply
Supply is described in Section 3 of the Therapeutic Goods Act 1989 as including:
- supply by way of sale, exchange, gift, lease, loan, hire or hire-purchase
- supply, whether free of charge or otherwise, by way of sample or advertisement
- supply, whether free of charge or otherwise, in the course of testing the safety or efficacy of therapeutic goods in persons
- supply by way of administration to, or application in the treatment of, a person